Fact-checked by Grok 2 weeks ago

Active ingredient

An active ingredient is any component of a product that is intended to produce the primary biological or chemical effect, such as providing pharmacological activity in drugs or controlling pests in pesticides.^[1]^[2] In pharmaceuticals, it is defined as any substance that furnishes pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease, or affects the structure or function of the body.^[1] Similarly, in pesticides, an active ingredient is a substance or group of substances that prevents, destroys, repels, or mitigates pests, including microorganisms, insects, or weeds.^[2] Active ingredients are central to the efficacy and regulation of various consumer and industrial products, including over-the-counter medications, agricultural chemicals, and certain personal care items with therapeutic claims.^[1]^[3] In drug formulations, the active pharmaceutical ingredient (API) is the key substance incorporated to achieve the intended therapeutic outcome, often combined with inactive excipients that facilitate manufacturing, stability, or delivery without contributing to the primary effect.^[4]^[5] Regulatory agencies like the U.S. Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA) require active ingredients to undergo rigorous safety and efficacy testing before approval, ensuring they meet standards for purity, potency, and labeling.^[1]^[2] The concentration and identity of active ingredients must be clearly declared on product labels to inform users and enable regulatory oversight, distinguishing them from inert components.^[5] In contexts like sunscreens or acne treatments, which are classified as drugs, active ingredients such as avobenzone or benzoyl peroxide are specifically listed to highlight their role in protection or treatment.^[6] This distinction is crucial for quality control, as variations in active ingredient composition can impact product performance and safety.^[5]

Definition and Concepts

Definition

An active ingredient is the biologically or chemically active substance in a formulated product, such as a drug or pesticide, that produces the intended therapeutic, prophylactic, or control effect. In pharmaceuticals, it refers to any component intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease, or to affect the structure or function of the body of humans or animals.^[1] In pesticides, it is defined as any substance or group of structurally similar substances that prevents, destroys, repels, or mitigates a pest, or acts as a plant regulator, defoliant, desiccant, or nitrogen stabilizer.^[2] This core component distinguishes itself by directly contributing to the product's efficacy, while other elements support delivery or stability. Representative examples illustrate the role of active ingredients across applications. In pharmaceuticals, acetylsalicylic acid, commonly known as aspirin, serves as the active ingredient for pain relief, fever reduction, and anti-inflammatory effects by inhibiting prostaglandin synthesis. In pesticides, glyphosate functions as the active ingredient in herbicides to control weeds by inhibiting the enzyme 5-enolpyruvylshikimate-3-phosphate synthase, essential for plant amino acid synthesis. These substances are typically present in precise, measurable concentrations, often expressed as a percentage by weight or volume, to ensure consistent performance and regulatory compliance.^[7] Active ingredients must exhibit potency and specificity to achieve their targeted effects at effective doses without undue interference from other components. Potency ensures the substance elicits the desired biological or chemical response efficiently, while specificity minimizes off-target impacts, a critical factor in safety assessments.^[8] Their concentrations are rigorously quantified during formulation and labeling to maintain efficacy and allow for dose-response evaluations. The term "active ingredient" emerged in the 20th century alongside the standardization of product formulations and regulatory frameworks, such as the U.S. Federal Food, Drug, and Cosmetic Act of 1938 for pharmaceuticals and the Federal Insecticide, Fungicide, and Rodenticide Act of 1947 for pesticides, which required clear identification of efficacy-driving components. This development facilitated quality control and consumer protection in increasingly complex mixtures.

Distinction from Other Components

In product formulations across industries such as pharmaceuticals, pesticides, and cosmetics, active ingredients are distinguished from other components, often referred to as excipients, inactive ingredients, or inert ingredients, which do not contribute to the primary functional effect but instead support the overall composition. Excipients are defined as any substances intentionally added to a formulation other than the active ingredient, serving roles such as aiding manufacturing processes, enhancing stability, improving bioavailability, facilitating delivery, or enhancing palatability.^[5]^[9] For instance, common excipients include binders like starch, fillers such as lactose or microcrystalline cellulose, preservatives like parabens or sodium benzoate, and solubilizers like polyethylene glycol.^[9] The fundamental difference lies in their roles: active ingredients exert the intended therapeutic, pesticidal, or functional effect, such as alleviating pain or controlling pests, while excipients provide auxiliary support without direct pharmacological, biological, or primary activity.^[1]^[10] In pharmaceutical products, for example, ibuprofen serves as the active ingredient responsible for analgesic and anti-inflammatory effects, whereas corn starch acts as an excipient to bind tablet components during compression and aid disintegration.^[11] This separation ensures that the active component's efficacy is not compromised by supportive materials, which may sometimes influence secondary aspects like absorption rates or shelf life but lack the core impact.^[9] Regulatory labeling requirements emphasize this distinction to promote transparency and safety, mandating that active ingredients be prominently identified, typically listed first with their quantities, ahead of excipients. In the United States, for over-the-counter pharmaceuticals, the Food and Drug Administration (FDA) requires active ingredients to appear under a dedicated "Active Ingredients" section on the label, followed by an "Inactive Ingredients" list, enabling consumers to quickly identify the primary agents.^[12] Similar conventions apply in other sectors, such as pesticides where the Environmental Protection Agency (EPA) requires active ingredients to be specified separately from inert ones on product labels.^[13]

Historical Development

The concept of active ingredients in medicinal preparations originated in ancient practices, where healers relied on whole herbal remedies without isolating specific components. For millennia, substances like opium from the Papaver somniferum plant were used in crude forms for pain relief and sedation, as documented in Egyptian, Greek, and Roman texts dating back to 3400 BCE, but the active principles within them remained unidentified until the modern era.^[14] Similarly, cinchona bark was employed by indigenous South American communities for treating fevers, predating its introduction to Europe in the 1600s as "Jesuit's bark" for malaria, yet its efficacy was attributed to the entire extract rather than any purified element.^[15] The 19th century marked a pivotal shift with the systematic isolation of active compounds from natural sources, laying the foundation for pharmaceutical chemistry. In 1803, German pharmacist Friedrich Sertürner successfully isolated morphine, the primary alkaloid responsible for opium's analgesic effects, marking the first extraction of a plant alkaloid in pure form after years of experimentation from 1803 to 1817.^[16] This breakthrough was followed in 1820 by French chemists Pierre Joseph Pelletier and Joseph Bienaimé Caventou, who isolated quinine from cinchona bark, enabling more reliable antimalarial treatments and spurring further alkaloid extractions like strychnine and caffeine.^[17] The early 20th century saw the rise of synthetic active ingredients, exemplified by acetylsalicylic acid (aspirin) developed by Felix Hoffmann at Bayer in 1897, which offered a purer, less irritating alternative to natural salicin for pain and inflammation.^[18] Advancements in the 20th century formalized the identification and standardization of active ingredients through regulatory measures and industrial scaling. The U.S. Pure Food and Drug Act of 1906, signed by President Theodore Roosevelt, prohibited misbranded drugs and required labeling of key ingredients, including potent substances like morphine and alcohol, to protect consumers from adulterated products and ensure transparency in formulations.^[19] By the 1950s, the pharmaceutical industry had evolved to emphasize the production of active pharmaceutical ingredients (APIs) as distinct, high-purity compounds, driven by post-World War II innovations in chemical synthesis and fermentation, such as the mass production of penicillin APIs, which transformed drug manufacturing from artisanal compounding to industrialized processes.^[20] In the modern era since 2000, research has increasingly focused on enhancing the bioavailability of active ingredients to improve therapeutic efficacy, particularly for poorly soluble compounds, through techniques like solid dispersions via hot-melt extrusion and spray drying, which have been incorporated into numerous FDA-approved drugs.^[21] Concurrently, patenting strategies for isolated active ingredients from natural sources have intensified, allowing protection of novel crystalline forms or derivatives to extend market exclusivity.

Applications in Industries

Pharmaceuticals

In pharmaceuticals, active pharmaceutical ingredients (APIs) are the key substances responsible for the therapeutic effects of a drug, providing pharmacological activity that diagnoses, treats, mitigates, or prevents disease, or affects the structure or function of the body.^[1] These ingredients interact with biological targets to produce the desired clinical outcomes, distinguishing them from inactive components that support delivery but do not contribute to efficacy.^[22] For instance, antibiotics like penicillin function as APIs by inhibiting bacterial cell wall synthesis, thereby targeting and eliminating susceptible gram-positive and gram-negative pathogens.^[23] APIs are formulated into various dosage forms, such as tablets, capsules, injectables, and topical preparations, where they are combined with excipients to enhance stability, solubility, and patient acceptability.^[24] Excipients, including binders, disintegrants, and surfactants, facilitate the release and absorption of the API, directly influencing bioavailability—the rate and extent to which the active ingredient reaches systemic circulation and becomes available at the site of action.^[25] In solid oral dosage forms, for example, excipients like alkalinizing agents or sugars can improve dissolution rates for poorly soluble APIs, optimizing therapeutic performance.^[26] Bioavailability considerations are critical during formulation to ensure consistent efficacy across different delivery systems.^[27] Representative examples illustrate the diverse applications of APIs. Paracetamol (acetaminophen), a widely used API, exerts analgesic and antipyretic effects by inhibiting a variant of the cyclooxygenase-1 enzyme, primarily for pain relief and fever reduction without significant anti-inflammatory activity at therapeutic doses.^[28] In lipid management, atorvastatin, a statin-class API, lowers cholesterol by competitively inhibiting HMG-CoA reductase, the enzyme that limits hepatic cholesterol synthesis, thereby reducing low-density lipoprotein levels and cardiovascular risk.^[29] Developing and manufacturing APIs present notable challenges, particularly in maintaining high purity, stability, and consistent physical form. Pharmaceutical standards typically require API purity exceeding 99% to minimize impurities that could compromise safety or efficacy, as outlined in international guidelines for controlling degradation products and unidentified impurities.^[30] Stability issues arise from environmental factors like temperature and humidity, which can lead to degradation when APIs interact with excipients, necessitating rigorous testing to predict and mitigate impurity formation.^[31] Additionally, polymorphism—the existence of multiple crystal forms of the same API—can alter solubility, dissolution rates, and bioavailability, potentially affecting therapeutic outcomes and requiring careful screening during development to select the most stable form.^[32]

Pesticides and Agriculture

In the context of pesticides and agriculture, active ingredients are the chemically active substances in pesticide formulations that prevent, destroy, repel, or mitigate target pests such as insects, weeds, or fungi, distinguishing them from inert carriers that provide stability or delivery without pesticidal effects.^[7] These compounds are required to be listed by name on product labels to ensure transparency and regulatory compliance.^[7] In agricultural applications, active ingredients form the core of pest management strategies, enabling farmers to protect crops from damage that could reduce yields by up to 40% without intervention. Pesticide active ingredients are categorized by the type of pest they target and their modes of action. Insecticides, for instance, include organophosphates such as malathion, which inhibit the enzyme acetylcholinesterase in insects, disrupting nerve impulses and leading to paralysis and death.^[33] Neonicotinoids like imidacloprid target the central nervous system of insects by binding to nicotinic acetylcholine receptors, causing overstimulation and eventual cessation of feeding and movement.^[33] Herbicides such as atrazine, a triazine compound, inhibit photosynthesis in broadleaf weeds and grasses by blocking electron transport in photosystem II, preventing the production of energy needed for plant growth.^[34] Fungicides like azoxystrobin, a strobilurin, interfere with mitochondrial respiration in fungi by inhibiting the Qo site of the cytochrome b-c1 complex, halting ATP production and spore germination.^[35] These diverse mechanisms allow for targeted control while minimizing impact on non-target crops when applied correctly. Active ingredients are applied through various methods to optimize efficacy and coverage in agricultural settings. Foliar sprays deliver the compounds directly onto plant surfaces for immediate pest contact, often used for insecticides and fungicides on row crops like corn and soybeans.^[36] Seed treatments coat seeds with active ingredients prior to planting, providing early-season protection against soil-borne pests and diseases; for example, neonicotinoid-treated seeds can protect seedlings from aphids during germination.^[37] Formulations typically contain 10-50% active ingredient by weight, with emulsifiable concentrates (ECs) ranging from 25% to 75% to balance solubility, stability, and application ease.^[36] Application rates are calibrated based on factors like crop type and pest pressure, ensuring minimal use while achieving control. Environmental concerns surrounding pesticide active ingredients center on their persistence and potential for bioaccumulation in ecosystems. Many compounds, particularly older organochlorines like DDT, exhibit high persistence with half-lives exceeding years in soil and water, leading to widespread contamination.^[38] DDT's bioaccumulation in food chains caused eggshell thinning in birds and neurological effects in wildlife, prompting its ban for agricultural use in the United States in 1972 under the Federal Insecticide, Fungicide, and Rodenticide Act.^[39] Modern active ingredients like neonicotinoids have shorter half-lives but can still leach into waterways, affecting non-target pollinators such as bees through sublethal exposure. Regulatory assessments now prioritize low-persistence profiles to mitigate these risks, with ongoing monitoring to evaluate long-term ecological impacts; as of 2025, several US states including California and Vermont have enacted further restrictions on non-agricultural uses of neonicotinoids to protect pollinators, building on federal and international efforts.^[7]^[40]

Cosmetics and Personal Care

In cosmetics and personal care products, active ingredients are key components designed to deliver targeted functional benefits to the skin, hair, or body, such as hydration, exfoliation, anti-aging effects, or protection from environmental damage.^[41] These substances differ from inert carriers or stabilizers by directly influencing product performance, often through biochemical interactions with biological tissues.^[42] For instance, retinoids, derivatives of vitamin A, promote cell turnover and collagen production to reduce the appearance of fine lines and wrinkles, while also helping to unclog pores and mitigate acne.^[43] Similarly, salicylic acid, a beta-hydroxy acid, exfoliates the skin's surface, penetrates pores to remove excess oil and debris, and provides anti-inflammatory benefits for clearer complexion.^[44] Common categories of active ingredients in these products include those for skincare, sunscreens, and hair care. In skincare, hyaluronic acid serves as a humectant that binds water to the skin, enhancing moisture retention and plumping the surface for a smoother texture.^[45] For sunscreens, avobenzone acts as a chemical filter that absorbs ultraviolet A (UVA) rays in the 320–400 nm wavelength range, preventing skin damage from photoaging and reducing the risk of skin cancer.^[46] In hair care, minoxidil stimulates hair follicles to promote growth and thicken existing strands, particularly in cases of androgenetic alopecia.^[47] Active ingredients in cosmetics are typically formulated at concentrations between 0.1% and 10% to balance efficacy and safety, with lower levels often sufficient for subtle benefits like hydration and higher ones for more pronounced effects like exfoliation.^[48] For example, over-the-counter retinoid products commonly use 0.1% to 1% retinol, salicylic acid appears at 0.5% to 2% for acne-prone skin, hyaluronic acid at 0.1% to 1% for moisturizing, avobenzone up to 3% in sunscreens, and minoxidil at 2% or 5% in hair regrowth treatments.^[49] Efficacy claims for these non-drug products are regulated to avoid implying medical treatment; for instance, statements like "moisturizes the skin" or "protects against UV rays" are permissible as cosmetic benefits, whereas claims such as "treats acne" or "cures baldness" classify the product as a drug requiring clinical proof under FDA or EU rules.^[50] In the European Union, such claims must be substantiated by evidence under Regulation (EC) No 1223/2009, ensuring they are truthful and not misleading.^[51] Safety considerations for active ingredients focus on potential allergens and irritants, with rigorous testing required to minimize risks like contact dermatitis. Parabens, once widely used as preservatives to prevent microbial growth, have faced scrutiny for endocrine-disrupting potential and allergic reactions, leading to their phase-out in some regions; the EU restricted propylparaben and butylparaben, limiting their combined concentration to no more than 0.14% as preservatives in leave-on cosmetic products and prohibiting their use in products applied to children under three years of age, due to safety concerns.^[52]^[53] In the US, while not fully banned, many manufacturers voluntarily reduced or eliminated parabens post-2010s in response to consumer demand and studies linking them to skin sensitivity.^[54] Other actives, such as retinoids and salicylic acid, may cause irritation in sensitive individuals at higher concentrations, necessitating patch testing and formulation with soothing agents.^[55]

Identification and Regulation

Analytical Methods

Analytical methods for active ingredients encompass a range of chromatographic and spectroscopic techniques designed to identify, separate, and quantify these compounds in complex matrices such as pharmaceuticals, pesticides, and cosmetics. High-performance liquid chromatography (HPLC) is a primary method for separation and detection, utilizing a stationary phase and mobile phase to isolate active ingredients based on their chemical properties, often coupled with detectors like ultraviolet (UV) for quantification.^[56] This technique is widely applied in pharmaceutical analysis to determine the concentration of active pharmaceutical ingredients (APIs) in formulations, ensuring compliance with purity requirements.^[57] Spectroscopic methods complement chromatography by providing structural confirmation and quantitative data. Ultraviolet-visible (UV-Vis) spectroscopy measures absorbance to quantify active ingredients through their characteristic absorption spectra, commonly used for compounds with chromophores in drug products.^[58] Nuclear magnetic resonance (NMR) spectroscopy offers detailed structural elucidation by analyzing molecular interactions with magnetic fields, essential for confirming the identity of isolated active ingredients in research and quality assurance.^[59] For quantitative analysis, techniques such as titration assess potency through chemical reactions, while mass spectrometry (MS), particularly liquid chromatography-mass spectrometry (LC-MS), enables precise measurement of purity and detection of trace impurities by ionizing and fragmenting molecules for mass-to-charge ratio analysis.^[60] LC-MS is particularly valuable for complex samples, providing high sensitivity for low-level contaminants in APIs and pesticide formulations.^[61] Reliable analysis relies on validated methods and reference standards. The United States Pharmacopeia (USP) provides certified reference standards for APIs, which serve as benchmarks for identity, strength, and purity testing in chromatographic and spectroscopic assays.^[62] Validation of these procedures follows International Council for Harmonisation (ICH) Q2(R1) guidelines, which outline parameters such as accuracy, precision, specificity, and linearity to ensure methods are suitable for their intended use in quantifying active ingredients. Emerging technologies enhance efficiency and enable real-time monitoring. Biosensors, integrating biological recognition elements with transducers, offer rapid detection of active ingredients in point-of-care settings, such as electrochemical or optical sensors for pesticide residues.^[63] Post-2020 developments incorporate artificial intelligence (AI) into spectroscopy, using machine learning algorithms to process spectral data for automated identification and quantification of active ingredients, improving accuracy in pharmaceutical quality control.^[64]

Quality Control and Standards

Quality control (QC) processes for active ingredients ensure their purity, potency, and stability throughout manufacturing and storage. Batch testing is a critical step, involving assays to verify potency, typically requiring the active content to fall within 95-105% of the labeled amount as per pharmacopeial monographs.^[65] Impurity levels are rigorously monitored, with identification required for degradation products exceeding the thresholds in ICH Q3A(R2), such as 0.10% or 1.0 mg per day intake (whichever is lower) for maximum daily intakes ≤2 g, to mitigate risks to safety and efficacy.^[66] Stability studies, guided by ICH Q1, evaluate active ingredients under accelerated and long-term conditions (e.g., 40°C/75% RH for six months) using at least three batches to predict shelf life and confirm no significant degradation.^[67] In pharmaceuticals, standards from the United States Pharmacopeia (USP) and European Pharmacopoeia (EP) set benchmarks for active pharmaceutical ingredients (APIs), including USP <1086> for impurity control and EP monographs for purity profiling.^[68]^[69] For pesticides, the U.S. Environmental Protection Agency (EPA) mandates certified limits for active ingredients under 40 CFR §158.350, requiring discussions of impurities and toxicologically significant contaminants below risk-based thresholds.^[70] In cosmetics and personal care, ISO 22716 outlines good manufacturing practices (GMP) for production and quality control of active ingredients, emphasizing personnel training, facility hygiene, and documentation to prevent contamination.^[71] Key metrics include content uniformity, assessed via USP <905> to ensure dosage units vary no more than 15% from the mean active content, supporting batch release.^[72] Dissolution rates, measured under USP <711>, gauge release profiles; for immediate-release forms, at least 80% (Q value) of the active ingredient must dissolve within 30 minutes in specified media.^[72] These metrics establish product performance and bioavailability. Counterfeits and adulteration pose significant challenges, often involving substandard active ingredients. Detection relies on techniques like Raman spectroscopy, which provides non-destructive, field-deployable identification of API composition by spectral fingerprinting, enabling rapid screening of suspect batches.^[73] This method has proven effective in distinguishing genuine from falsified products, supporting supply chain integrity.^[74]

Regulatory Frameworks

Regulatory frameworks for active ingredients ensure safety, efficacy, and quality across pharmaceuticals, pesticides, and cosmetics by mandating approvals, registrations, and labeling requirements tailored to each sector. These structures vary by jurisdiction but increasingly emphasize harmonization to facilitate global trade while addressing risks like contamination or supply disruptions. As of 2025, recent ICH updates include a draft revision to Q1 on stability testing and FDA's extension of ICH Q7 to veterinary APIs in 2024, enhancing harmonized standards for active ingredients.^[75]^[76] In the pharmaceutical sector, the U.S. Food and Drug Administration (FDA) requires approval of active pharmaceutical ingredients (APIs) through a New Drug Application (NDA) for innovative drugs, which demonstrates safety and efficacy via clinical data, or an Abbreviated New Drug Application (ANDA) for generics, relying on bioequivalence to reference products.^[77] Approved APIs are listed in the FDA's Orange Book, which catalogs drug products with therapeutic equivalence evaluations to guide generic substitutions.^[78] In the European Union, the European Medicines Agency (EMA) oversees APIs through Marketing Authorisation Applications (MAAs), with scientific guidelines specifying quality requirements for active substances, including manufacturing and impurity controls, to support centralized or decentralized authorizations.^[79] For pesticides, the U.S. Environmental Protection Agency (EPA) mandates registration of active ingredients under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) of 1947, evaluating risks to human health and the environment before allowing market entry.^[80] Registered pesticides must adhere to maximum residue limits (MRLs), set as tolerances to protect consumers from excessive exposure in food, with the EPA establishing these based on toxicological data and exposure assessments.^[81] In cosmetics, the FDA does not require pre-market approval for active ingredients but enforces labeling regulations under the Federal Food, Drug, and Cosmetic Act, requiring principal display panels to list ingredients in descending order of predominance, excluding incidental additives, to inform consumers and prevent misbranding.^[82] In the EU, the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) regulation assesses the chemical safety of substances, including those used as active ingredients in cosmetics, by requiring registration and risk evaluations for volumes over one ton annually to ensure human health and environmental protection.^[83] This complements the Cosmetics Regulation (EC) No 1223/2009, which bans or restricts hazardous ingredients and mandates safety assessments before market placement.^[84] Global harmonization efforts, led by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), provide unified guidelines such as ICH Q7 on good manufacturing practices for APIs, covering production, quality control, and documentation to align standards across regions like the U.S., EU, and Japan.^[85] Post-2020, amid COVID-19-induced disruptions that exposed vulnerabilities in API supply chains—such as reliance on single suppliers and transportation delays—regulatory bodies like the FDA and EMA updated oversight to enhance traceability, including mandatory notifications of manufacturing interruptions under Section 506C of the FD&C Act and EMA's monitoring of critical medicine availability.^[86]^[87] These measures, informed by ICH principles, promote resilient supply chains through risk-based audits and international data sharing, as outlined in post-pandemic reports.^[88]

Natural and Herbal Sources

Herbal Medicine

In herbal medicine, active ingredients consist of bioactive compounds extracted from plants that contribute to therapeutic effects in traditional and contemporary formulations. These compounds encompass diverse classes, such as alkaloids, which are nitrogen-containing bases like caffeine in tea leaves (Camellia sinensis), functioning as a central nervous system stimulant to promote alertness and reduce fatigue. Flavonoids, another key group, include quercetin in onions (Allium cepa), which exhibits antioxidant and anti-inflammatory properties by scavenging free radicals and inhibiting oxidative stress pathways. These plant-derived actives form the basis of many herbal remedies, where their pharmacological actions underpin uses ranging from cognitive enhancement to immune support. Specific examples illustrate the therapeutic potential of these compounds. Ginsenosides, steroidal saponins in ginseng (Panax ginseng), are recognized for their adaptogenic effects, enhancing energy metabolism and physical performance by modulating stress responses and improving mitochondrial function in preclinical models. Likewise, curcumin, the primary polyphenolic active in turmeric (Curcuma longa), demonstrates anti-inflammatory activity through inhibition of nuclear factor-kappa B (NF-κB) and cyclooxygenase-2 (COX-2) pathways, supporting its traditional use in managing inflammatory conditions like arthritis. Standardization of herbal products addresses inherent variability arising from plant sources, including genetic differences, environmental factors, and cultivation practices, which can lead to inconsistent active content across batches. Quality control relies on marker compounds—specific, quantifiable constituents indicative of potency—such as standardizing concentrated turmeric extracts to 95% curcuminoids to ensure reproducible efficacy and safety.^[89] This approach mitigates risks of subtherapeutic dosing or contamination, aligning herbal medicines with pharmaceutical-grade consistency. In modern applications, plant-derived active ingredients serve as herbal active pharmaceutical ingredients (APIs) in dietary supplements, bridging traditional knowledge with evidence-based practice. Post-1990s clinical trials have substantiated their integration; for instance, St. John's wort (Hypericum perforatum) extracts, standardized to hypericin or hyperforin, demonstrated efficacy in treating mild to moderate depression in multiple randomized controlled studies from the era, often comparable to selective serotonin reuptake inhibitors with fewer side effects.

Extraction and Isolation Techniques

The extraction and isolation of active ingredients from natural sources, particularly plants, rely on a range of techniques designed to efficiently separate bioactive compounds while preserving their chemical integrity. Basic methods form the foundation of these processes, with solvent extraction being one of the most widely used approaches for obtaining polar and semi-polar compounds such as alkaloids. In solvent extraction, plant material is typically macerated or pulverized and then treated with organic solvents like ethanol or methanol, which dissolve the target compounds based on their solubility; for instance, ethanol is commonly employed to extract alkaloids from plant tissues by protonating their basic nitrogen groups, facilitating selective isolation.^[90]^[91] Another fundamental technique is distillation, particularly steam distillation, which is ideal for volatile active ingredients like essential oils. This method involves passing steam through the plant material to vaporize and carry away the oils, which are then condensed and separated from the water phase, yielding high-purity extracts without thermal degradation of heat-sensitive components.^[92]^[93] Advanced methods enhance precision and efficiency in purification, addressing the limitations of basic extractions by enabling the separation of complex mixtures. Chromatography techniques, such as flash chromatography and preparative high-performance liquid chromatography (HPLC), are pivotal for isolating pure active ingredients from crude extracts; flash chromatography uses pressurized solvent flow through a silica gel column for rapid separation based on differential adsorption, while preparative HPLC employs gradient elution with reverse-phase columns to achieve high-resolution purification of compounds like flavonoids or terpenoids from plant matrices.^[94]^[90] Complementing these, supercritical CO2 extraction represents a non-toxic, environmentally friendly alternative that utilizes carbon dioxide in its supercritical state (above 31°C and 73.8 bar) as a solvent to selectively extract lipophilic actives, such as cannabinoids or antioxidants, without leaving residues and allowing easy solvent recovery by pressure reduction.^[95]^[96] Recent advances as of 2024-2025 include ultrasound-assisted extraction (UAE) and enzyme-assisted extraction, which use sound waves or enzymes to disrupt cell walls, improving yields by up to 50% while reducing energy and solvent consumption for sustainable processing.^[97] Optimizing extraction yields is crucial for economic viability, with key parameters including temperature, pH, solvent ratio, and extraction time tailored to the compound's stability and solubility. Higher temperatures generally increase diffusion rates and yields but risk degrading thermolabile actives, while pH adjustments—such as acidic conditions for alkaloids—enhance ionization and extraction efficiency; for example, phenolic yields from plant materials peak at pH 4.0 and 60°C, balancing extraction rate with compound preservation. A notable case is the isolation of paclitaxel, an anticancer diterpenoid, from the bark of Taxus brevifolia (Pacific yew), where yields are approximately 0.01% of dry bark weight using solvent-based methods like methylene chloride extraction followed by chromatography, a process that has been scaled industrially since the 1990s to meet pharmaceutical demands through optimized precipitation and purification steps.^[98]^[99]^[100] Scaling up extraction and isolation from laboratory to industrial levels involves adapting processes to larger volumes while maintaining yield and purity, often integrating bioreactor systems for sustainable production. For plant-derived actives, biotech fermentation using plant cell cultures—such as Taxus species for paclitaxel—allows controlled growth in large-scale fermenters (up to thousands of liters), followed by downstream extraction via centrifugation and chromatography, achieving consistent outputs that bypass seasonal plant harvesting limitations and support annual production exceeding hundreds of kilograms.^[101]^[102]^[103]

References

[1]
Drugs@FDA Glossary of Terms
Nov 14, 2017 · An active ingredient is any component that provides pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or ...
[2]
40 CFR 158.300 -- Definitions. - eCFR
Active ingredient means any substance (or group of structurally similar substances, if specified by the Agency) that will prevent, destroy, repel or mitigate ...
[3]
PRIA Glossary | US EPA
Apr 17, 2025 · A. Active Ingredient - The active ingredient in a pesticide product is the component which kills/controls the target pest.
[4]
21 CFR 207.1 -- What definitions and interpretations of terms apply ...
Active pharmaceutical ingredient means any substance that is intended for incorporation into a finished drug product and is intended to furnish pharmacological ...
[5]
Inactive Ingredients in Approved Drug Products Search - FDA
Jan 26, 2022 · According to 21 CFR 210.3(b)(7), an active ingredient is any component of a drug product intended to furnish pharmacological activity or other ...What is an active ingredient? · Can an inactive ingredient...
[6]
Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?) - FDA
Sep 11, 2024 · For example, the drug ingredients must be listed alphabetically as "Active Ingredients," followed by cosmetic ingredients, listed in ...
[7]
Basic Information about Pesticide Ingredients | US EPA
Active ingredients are the chemicals in a pesticide product that act to control the pests. Active ingredients must be identified by name on the pesticide ...
[8]
Q7A Good Manufacturing Practice Guidance for Active ... - FDA
Active Pharmaceutical Ingredient (API) (or Drug Substance): Any substance or mixture of substances intended to be used in the manufacture of a drug (medicinal) ...
[9]
[PDF] Guidance for Industry - FDA
However, we recommend that the applicant identify and characterize the differences in excipients and provide information demonstrating that the differences do ...
[10]
Inert Ingredients Overview and Guidance | US EPA
May 30, 2025 · An inert ingredient generally is any substance (or group of similar substances) other than an active ingredient that is intentionally included in a pesticide ...
[11]
[PDF] ADVIL (IBUPROFEN) Label - accessdata.fda.gov
Dec 14, 2021 · pregelatinized starch, propylparaben, sodium benzoate ... Questions or comments? call toll free 1-800-88-ADVIL. Drug Facts. Active ingredient.
[12]
The Over-the-Counter Drug Facts Label - FDA
Oct 25, 2024 · Active Ingredient(s). The substance(s) in the product that cause the intended therapeutic effect. This also states the amount of substance(s) ...
[13]
Inert Ingredients Regulation | US EPA
Feb 27, 2025 · An inert ingredient generally is any substance (or group of similar substances) other than an active ingredient that is intentionally included in a pesticide ...
[14]
A Brief History of Opioids in the U.S.
Nov 8, 2023 · He named the new compound after Morpheus, the Greek god of dreams. “Everything changed with the isolation of morphine from the poppy plant,” ...
[15]
What Historical Records Teach Us about the Discovery of Quinine
The first official record of a prescription for Peruvian bark in Rome dates to the early 1630s by the Jesuit Domenico Anda, chief apothecary at the Hospital of ...
[16]
The isolation of morphine by Serturner - PMC - NIH
The isolation of morphine in its pure form was the result of years of research and testing, occurring most prominently between the years 1803 and 1817.Missing: fact | Show results with:fact<|control11|><|separator|>
[17]
Cinchona Bark - an overview | ScienceDirect Topics
In 1820, Pierre Joseph Pelletier and Joseph Bienaimé Caventou successfully isolated quinine (Fig. 11.2) from the cinchona bark and identified it as the main ...
[18]
[PDF] Early drug discovery and the rise of pharmaceutical chemistry
Apr 28, 2011 · Aspirin - a wonder drug Aspirin was marketed as a highly successful pharmaceutical product by the Bayer Company in 1897, although plant ...
[19]
Part I: The 1906 Food and Drugs Act and Its Enforcement | FDA
Apr 24, 2019 · On 30 June 1906 President Roosevelt signed the Food and Drugs Act, known simply as the Wiley Act, a pillar of the Progressive era.Missing: active | Show results with:active
[20]
Big Pharma's Drug War: Innovative vs. Generic and Biosimilar Drugs
Feb 16, 2018 · A little history The pharmaceutical industry of the 1950s was based on branded formulations of a small number of active ingredients. Each ...
[21]
Bioavailability & Solubility: The Promise of Novel Ingredients
Primary technologies that were used to improve solubility in FDA-approved products since 2000 are hot melt extrusion and spray drying to form solid dispersion; ...Missing: modern post-
[22]
Marketing authorization and strategic patenting - ScienceDirect.com
Promising drug candidates (active ingredients/NMEs) are often included in patent filings right after discovery. These initial NME patents are considered “ ...Missing: modern | Show results with:modern
[23]
Glossary - EudraGMDP - European Union
A. Active Pharmaceutical Ingredient. Any substance, or mixture of substances, intended to be used in the manufacture of a drug (medicinal) product and that, ...
[24]
Penicillin - StatPearls - NCBI Bookshelf - NIH
Penicillin is effective against infections caused by gram-positive cocci, gram-positive rods, most anaerobes, and gram-negative cocci.
[25]
Pharmaceutical Excipients and Drug Metabolism: A Mini-Review - NIH
Nov 3, 2020 · The functional roles of pharmaceutical excipients include modulating bioavailability and solubility of APIs, increasing the stability of APIs ...
[26]
[PDF] Definition of Bioavailability and Bioequivalence - FDA
Bioavailability means the rate and extent to which an active ingredient is absorbed from a drug product and becomes available at the site of action. For ...
[27]
The Role of Functional Excipients in Solid Oral Dosage Forms ... - NIH
Apr 25, 2020 · This paper provides an overview of selected excipients (eg, alkalinizing agents, surfactants and sugars) that can be used in formulations to increase the ...
[28]
The Bioavailability of Drugs—The Current State of Knowledge - PMC
Dec 11, 2023 · Relative bioavailability is expressed as the ratio of the bioavailability of two dosage forms of the same drug (Figure 1). We can compare ...
[29]
Acetaminophen - StatPearls - NCBI Bookshelf - NIH
Jan 11, 2024 · Acetaminophen, also known as N-acetyl-para-aminophenol (APAP) or paracetamol in many countries, is a non-opioid analgesic and antipyretic agent ...
[30]
Atorvastatin - StatPearls - NCBI Bookshelf - NIH
Aug 3, 2025 · Atorvastatin also increases the number of LDL receptors on the surface of hepatic cells and decreases the LDL levels.Missing: ingredient | Show results with:ingredient
[31]
[PDF] Impurities in new drug substances Q3A (R2) - ICH
Oct 25, 2006 · This ICH guideline provides guidance for registration applications on the content and qualification of impurities in new drug substances, ...
[32]
Predicting Degradation Related Impurities and Impurity ... - NIH
It is quite common that the API will show stability issues when blended with excipients. There are often significant challenges with surprise degradation ...
[33]
Polymorph Impact on the Bioavailability and Stability of Poorly ... - NIH
Polymorphs (anhydrous and solvate/hydrate forms) may resolve these bioavailability problems, but they can be a challenge to ensure physicochemical stability.
[34]
Chemically-related Groups of Active Ingredients | US EPA
Sep 23, 2025 · Many pesticide active ingredients affect pests in similar ways, and we re-evaluate them together as a group. Groups include carbamate ...Missing: definition | Show results with:definition
[35]
Atrazine | US EPA
Atrazine is a chlorinated triazine systemic herbicide that is used to selectively control annual grasses and broadleaf weeds before they emerge.
[36]
Pesticides Fact Sheet for Azoxystrobin 1997 - epa nepis
... active ingredient, Azoxystrobin, to Zeneca Ag Products. The use pattern ... Physical/Chemical Properties of Azoxystrobin Active Ingredient Color: White ...
[37]
Pesticide Formulations - Ask IFAS - University of Florida
Most ECs contain between 25% and 75% (2–8 pounds) active ingredient per gallon. ECs are among the most versatile formulations. They are used against ...Missing: methods levels
[38]
Occupational Pesticide Exposure - Seed Treatment | US EPA
Application rate: the amount of active ingredient applied to the seed (e.g., milligrams of active ingredient per pound of seed), as described on the pesticide ...Missing: concentration | Show results with:concentration
[39]
DDT - A Brief History and Status | US EPA
Sep 11, 2025 · After the use of DDT was discontinued in the United States, its concentration in the environment and animals has decreased, but because of its ...Missing: bioaccumulation | Show results with:bioaccumulation
[40]
DDT Regulatory History: A Brief Survey (to 1975) | About EPA
Sep 14, 2016 · On June 14, 1972, the EPA Administrator announced the final cancellation of all remaining crop uses of DDT in the U.S. effective December 31, ...Missing: ingredients | Show results with:ingredients
[41]
Cosmetics Active Ingredients Analysis - Intertek
Examples of skincare active ingredients include peptides, vitamins such as Vitamin A, Vitamin C or Vitamin E, hyaluronic acid, preservatives and more. These ...
[42]
The Roles of Product Ingredients - Dermascope
Examples of active or performance ingredients include hydroxy acids used in anti-aging and exfoliation products, tretinoin or benzoyl peroxide found in acne ...
[43]
How Active Ingredients Act on Skin - Northwestern Medicine
Retinoids help the skin grow more evenly. This helps prevent acne by unclogging pores and preventing dead skin cells from clogging pores. Retinoids also help ...
[44]
Understanding Skin Care Products - WebMD
Apr 17, 2025 · Beta-Hydroxy Acid (Salicylic Acid) Salicylic acid exfoliates skin, unclogs pores and can improve its texture and color. It also helps with acne.
[45]
Salicylic acid and hyaluronic acid : Why using them together?
Both hyaluronic and salicylic acids act on signs of aging, helping skin to stay smooth and giving it extra volume. Hydrating More than simply moisturizing skin, ...
[46]
Avobenzone: Uses, Interactions, Mechanism of Action - DrugBank
Avobenzone has the ability to absorb ultraviolet light over wider range of wavelengths. It is included in many commercially available sunscreens which are used ...
[47]
Minoxidil (topical route) - Side effects & dosage - Mayo Clinic
Feb 1, 2025 · Minoxidil applied to the scalp is used to stimulate hair growth in adult men and women with a certain type of baldness.Description · Before Using · Proper Use
[48]
Skin Care Ingredients Dictionary: From AHAs to Zinc Oxide
Sep 1, 2022 · Salicylic acid is the most common BHA. It acts as an exfoliant and keeps pores clear of breakout-triggering bacteria. It can reduce the ...Missing: avobenzone | Show results with:avobenzone
[49]
Decoding Active Ingredients: Concentration Levels That Deliver ...
0.01-0.03%: Found in many drugstore products, these mild concentrations may help with minor texture issues but offer limited visible results. 0.25-0.5%: This ...Vitamin C: Stability Matters... · Exfoliating Acids: Balance... · Niacinamide: The Versatile...Missing: avobenzone minoxidil
[50]
Cosmetics & U.S. Law - FDA
May 2, 2024 · How U.S. Law Defines Drugs ... Certain claims may cause a product to qualify as a drug, even if the product is marketed as if it were a cosmetic.Missing: non- | Show results with:non-
[51]
40 key differences of US & EU cosmetics regulation - SkinConsult
Nov 24, 2023 · USA: The FDA has prohibited or restricted fewer ingredients compared to the EU. Manufacturers are responsible for ensuring product safety, with ...
[52]
Parabens in Cosmetics - FDA
Feb 25, 2022 · Parabens are commonly used as preservatives in cosmetics. Here are answers to questions that consumers often ask about the safety and use of these ingredients.
[53]
The dark side of beauty: an in-depth analysis of the health hazards ...
The European Union has enacted legislation to limit the use of parabens in makeup, beauty, or personal care products. Recently, in 2014, the European Union ...
[54]
Popular Skin Care Ingredients Explained
Aug 2, 2022 · “In many cases, salicylic acid can be less irritating than skin care products containing alpha-hydroxy acids,” explains Dr. Bergfeld. “But they ...
[55]
HPLC in pharmaceutical analytics - 2023 - Wiley Analytical Science
May 12, 2023 · In the pharmaceutical sector – in product development as well as in quality control – the HPLC technique is the most important analytical key ...
[56]
Active Ingredient Analysis: Methods And Applications in Product ...
Oct 16, 2024 · By using various detectors such as UV, fluorescence, or mass spectrometry (MS), HPLC can detect both small and large molecules.
[57]
HPLC and UV Spectroscopy in Pharmaceutical Analysis
Aug 7, 2025 · Ultraviolet (UV) spectroscopy and High-Performance Liquid Chromatography (HPLC) are two essential analytical methods that are frequently ...
[58]
Comparative Analysis of Benchtop NMR and HPLC‐UV for Illicit ...
Aug 18, 2025 · This study evaluates the feasibility of benchtop NMR spectroscopy for the quantitative analysis of methamphetamine hydrochloride in binary ...
[59]
Quantitative mass spectrometry methods for pharmaceutical analysis
Quantitative pharmaceutical analysis is nowadays frequently executed using mass spectrometry. Electrospray ionization coupled to a (hybrid) triple quadrupole ...Missing: titration | Show results with:titration
[60]
What Is LC-MS, LC-MS Analysis and LC-MS/MS
Jul 30, 2024 · LC-MS is an analytical technique that involves physical separation of target compounds (or analytes) followed by their mass-based detection.Missing: titration | Show results with:titration
[61]
USP Reference Standards
USP standards for drug reference standards are used to demonstrate identity, strength, purity and quality for medicines, dietary supplements and food ...FAQs · Use and Storage of USP... · Person_outline · Here
[62]
https://www.usp.org/reference-standards
[63]
Integrating AI and advanced spectroscopic techniques for precision ...
This review highlights the integration of advanced spectroscopy, AI-driven analysis, and novel sensor technologies, outlining future strategies.Missing: post- | Show results with:post-
[64]
[PDF] SPECIFICATIONS AND CONTROL TESTS ON THE FINISHED ...
The wider limits also include both, the variation of the production and of the test procedure for the assay.
[65]
[PDF] Q 1 A (R2) Stability Testing of new Drug Substances and Products
The purpose of the stability study is to establish, based on testing a minimum of three batches of the drug substance and evaluating the stability information ...
[66]
[PDF] 1086 IMPURITIES IN DRUG SUBSTANCES AND DRUG ... - USP-NF
Impurities in drugs affect safety and efficacy, arising from manufacturing or storage. This chapter provides guidance on controlling these impurities, but ...
[67]
[PDF] Impurity Control in the European Pharmacopoeia
➢ Which impurities are controlled? ➢ Analytical techniques and general texts/monographs. ➢ Control of organic impurities. ➢ Validation. ➢ Elemental impurities.
[68]
40 CFR 158.350 -- Certified limits. - eCFR
The applicant must propose certified limits for the ingredients in the product. Certified limits become legally binding limits upon approval of the application.
[69]
ISO 22716:2007 - Cosmetics — Good Manufacturing Practices (GMP)
In stock 2–5 day deliveryISO 22716:2007 gives guidelines for the production, control, storage and shipment of cosmetic products. These guidelines cover the quality aspects of the ...
[70]
[PDF] 〈711〉 DISSOLUTION - US Pharmacopeia (USP)
Dissolution test smooth, vertically reciprocating cylinder. A device is used procedures using a flow-through cell must be characterized that allows the ...
[71]
Determination of counterfeit medicines by Raman spectroscopy
Aug 10, 2015 · Raman spectroscopy, combined with chemometric techniques, is used to determine counterfeit medicines by discriminating between different ...
[72]
Benchtop and Portable Raman Spectrometers to Screen Counterfeit ...
Apr 22, 2020 · This article discusses a portable Raman spectroscopic technique which can be deployed in the field to detect counterfeit drugs.
[73]
Abbreviated New Drug Application (ANDA) - FDA
Oct 3, 2025 · An abbreviated new drug application (ANDA) contains data which is submitted to FDA for the review and potential approval of a generic drug product.Missing: EMA | Show results with:EMA
[74]
Approved Drug Products with Therapeutic Equivalence Evaluations
Oct 10, 2025 · FDA's Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) identifies drug products approved on the basis of safety and ...Missing: EMA | Show results with:EMA
[75]
Quality: active substance | European Medicines Agency (EMA)
The European Medicines Agency's scientific guidelines on the quality aspects of active substances help medicine developers prepare marketing authorisation ...
[76]
Pesticide Registration | US EPA
Sep 2, 2025 · This site provides resources for an individual or company wanting to register a pesticide active ingredient or pesticide product in the UnitedAbout Pesticide · Overview of Registration Types · Registration Manual · Devices
[77]
Regulation of Pesticide Residues on Food | US EPA
We set tolerances, which are the maximum amount of a pesticide allowed to remain in or on a food, as part of the process of regulating pesticides.How to Search for Tolerances · Setting Tolerances for... · OECD CalculatorMissing: FIFRA | Show results with:FIFRA
[78]
Summary of Cosmetics Labeling Requirements - FDA
Dec 1, 2022 · The ingredients must be identified by the names established or adopted by regulation (21 CFR 701.3(c)); those accepted by the FDA as exempt from ...Legal Definition of "Cosmetics" · Cosmetic Labeling · Declaration of Ingredients<|control11|><|separator|>
[79]
Understanding REACH - ECHA - European Union
This is unique source of information on the chemicals manufactured and imported in Europe. It covers their hazardous properties, classification and labelling, ...Missing: cosmetics | Show results with:cosmetics
[80]
legislation-profile - ECHA - European Union
Scope. Establishes rules for all cosmetic products made available on the market, in order to ensure the functioning of the internal market and the safety of ...
[81]
[PDF] Q7 Guideline - ICH
The ICH Q7 guideline is a Good Manufacturing Practice guide for active pharmaceutical ingredients, recommended for adoption by the EU, Japan, and USA.
[82]
Supply Chain News, Reports and Publications | FDA
Aug 8, 2025 · The report includes four-year reviews of supply chains for agri-food, pharmaceuticals and active pharmaceutical ingredients, and the public ...
[83]
Availability of medicines during COVID-19
The European medicines regulatory network has closely monitored the supply of critical medicines for COVID-19 during the pandemic.Missing: traceability ingredients ICH FDA
[84]
[PDF] Securing Medical Supply Chains in a Post-Pandemic World - OECD
The pandemic strained medical supply chains, highlighting issues in manufacturing quality, economic factors, and high concentration of manufacturing steps in ...
[85]
Techniques for extraction and isolation of natural products
Apr 17, 2018 · Alcohols (EtOH and MeOH) are universal solvents in solvent extraction for phytochemical investigation. Generally, the finer the particle size is ...<|separator|>
[86]
Preparation of Medicinal Plants: Basic Extraction and Fractionation ...
Jan 29, 2020 · Solvents commonly used in extraction of medicinal plants are polar solvent (e.g., water, alcohols), intermediate polar (e.g., acetone ...
[87]
Steam Distillation - an overview | ScienceDirect Topics
Steam distillation is defined as a process for extracting essential oils from plant materials by immersing them in boiling water or steam, which disrupts ...
[88]
A Comprehensive Guide to Essential Oil Extraction Methods
Mar 20, 2017 · Steam Distillation is the most popular method used to extract and isolate essential oils from plants for use in natural products.Production of Essential Oils · Steam Distillation · Solvent Extraction · CO2 Extraction
[89]
Isolation of Natural Products by Preparative High Performance ...
Isolation of Natural Products by Preparative High Performance Liquid Chromatography (Prep-HPLC) ... Flash Chromatography. Gradient Elution. Isocratic Elution.
[90]
Recent Advances in Supercritical Fluid Extraction of Natural ...
This work aims to discuss the recent advances in supercritical fluid extraction techniques, especially supercritical carbon dioxide, along with the fundamental ...
[91]
Extraction of natural products using supercritical fluids and ...
This work presents a comprehensive review and current insights into the use of high-pressure systems, specifically supercritical fluid extraction and ...
[92]
Effects of Various Temperatures and pH Values on the Extraction ...
Extraction was most efficient at pH 4.0, while an extraction temperature of 60 °C was the best in terms of the combined extraction yield of phenolics and the ...
[93]
Optimization of the Extraction Conditions of Antioxidant Phenolic ...
Mar 29, 2023 · The optimal extraction conditions for both responses were determined to be time of 17.5 min, temperature 52.5 °C, and liquid/solid ratio of 30:1.Reducing Power Assay Frap · Results And Discussion · Solvent Selection For...
[94]
A new large-scale process for taxol and related taxanes from Taxus ...
The current isolation methods starting from the bark of Taxus brevifolia involve multiple manipulations, leading to only taxol and in a yield of 0.01%. A ...Missing: industrial | Show results with:industrial
[95]
A large-scale purification of paclitaxel from cell cultures of Taxus ...
A large-scale purification method was developed for producing paclitaxel, to guarantee high purity and yield from plant cell cultures.
[96]
Scale-Up Fermentation Service - BOC Sciences
Scale-up fermentation refers to the conversion of a laboratory-developed process to a full manufacturing scale process. The pilot-scale fermentation with ...
[97]
Optimization and Scale-Up of Fermentation Processes Driven by ...
Sep 14, 2022 · This paper first introduces two mechanistic modeling methods, kinetic modeling and constraint-based modeling (CBM), and generalizes their applications in ...